Skip to content

Rezolute, Inc.

RZLT· NasdaqCore metricsCIK 1509261

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -5.02%
Market cap
$374.82M
96.73M shares
Filings
767
—
—
—
-$18.49M
Q1 2027N/M FY26 yoy
-$19.39M
Q1 2027N/M FY26 yoy
-$44.63M
FY 2023derivedN/M FY23 yoy
-$0.18
Q1 2027N/M FY26 yoy
$8.15M
Q1 2027−88.7% FY26 yoy
$374.82M
—
—
4.4×
—
—

FY2026 figures · derived

Price

$3.8861.37%$6.15past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$53.80MFY 2026
$61.53M0FY 2015FY 2020FY 2026
PeriodEndedValueKindSource trail
FY 20262026-06-30$53,798,000reported
FY 20252025-06-30$61,527,000reported
FY 20242024-06-30$55,743,000reported
FY 20232023-06-30$43,813,000reported
FY 20222022-06-30$32,486,000reported
FY 20212021-06-30$14,987,000reported
FY 20202020-06-30$14,450,000reported
FY 20192019-06-30$19,079,000reported
FY 20182018-06-30$17,280,000reported
FY 20172017-06-30$12,094,734reported
FY 20162016-06-30$9,448,388reported
FY 20152015-06-30$4,701,209reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$3.00K$3.00K—55.37M sh+50.3%—

Pharmaceutical preparations

Rezolute, Inc. is the 209th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Rezolute, Inc. · CIK 1509261 · Engraved from SEC EDGAR